You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medtronic (MDT) demonstrates weak fiscal fourth-quarter performances at CER, attributable to dismal show in all major business segments and geographies.
Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.
U.S. stock markets closed lower on Tuesday following the news that a potential vaccine candidate for the treatment of the coronavirus may not be effective.
medical: Archive
Cigna Adds Capabilities to Expand Its Virtual Care Service
by Zacks Equity Research
Cigna (CI) has added a private messaging application to better serve its members amid COVID-19 breakout.
HUM CI CVS ANTM
medical
Why Liquidia Technologies (LQDA) Stock Might be a Great Pick?
by Zacks Equity Research
Liquidia Technologies (LQDA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
LQDA
medical
Company News for May 22, 2020
by Zacks Equity Research
Companies In The News Are: MDT, BJ, SNPS, EXPE.
MDT EXPE BJ SNPS
consumer-discretionary medical retail tech-stocks
Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Gritstone Oncology (GRTS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
GRTS
medical
How Kiniksa Pharmaceuticals (KNSA) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Kiniksa Pharmaceuticals (KNSA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
KNSA
medical
How Concert Pharmaceuticals (CNCE) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Concert Pharmaceuticals (CNCE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
CNCE
medical
Is AbbVie (ABBV) Stock a Solid Choice Right Now?
by Zacks Equity Research
AbbVie (ABBV) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
ABBV
medical
Pick These 5 Stocks With Superb Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
BJ HEAR AAWW VERI ATXI
business-services computers consumer-discretionary medical transportation
Co-Diagnostics' Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Co-Diagnostics.
CODX
medical
Galectin Therapeutics' Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Galectin Therapeutics.
GALT
medical
4 Breakout Stocks for Impressive Returns
by Nitish Marwah
The logic behind the breakout strategy for stock selection is to identify stocks are trading within a narrow band.
AUY GLUU ATXI YAHOY
consumer-discretionary gold internet medical
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
Riding high on its growing revenues and financial strength, Molina Healthcare (MOH) has potential to reap benefits to its investors.
UNH MOH CNC ANTM
medical
Medtronic (MDT) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks.com
Medtronic (MDT) demonstrates weak fiscal fourth-quarter performances at CER, attributable to dismal show in all major business segments and geographies.
BIIB MDT LLY APHA
earnings medical
Coronavirus Vaccine Race Pushes Up Pharma Giants' Production
by Ritujay Ghosh
Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.
SNY PFE MRNA BNTX
biotechs medical pharmaceuticals
Top Ranked Momentum Stocks to Buy for May 22nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 22nd.
GMDA CALM AAWW
airlines consumer-staples medical
Top Ranked Income Stocks to Buy for May 22nd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, May 22nd.
SJM BGS ASX ABBV
consumer-staples medical semiconductor
Company News for May 21, 2020
by Zacks Equity Research
Companies In The News Are: MRNA, FB, CLX, RCL.
MRNA RCL CLX FB
consumer-discretionary consumer-staples medical tech-stocks
Why IVERIC bio (ISEE) Stock Might be a Great Pick
by Zacks Equity Research
IVERIC bio (ISEE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
ISEE
medical
How MEI Pharma (MEIP) Stock Stands Out in a Strong Industry
by Zacks Equity Research
MEI Pharma (MEIP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
MEIP
medical
Is Mustang (MBIO) Stock a Solid Choice Right Now?
by Zacks Equity Research
Mustang (MBIO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
MBIO
medical
How La Jolla (LJPC) Stock Stands Out in a Strong Industry
by Zacks Equity Research
La Jolla (LJPC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
LJPC
medical
Why You Shouldn't Bet Against Karuna Therapeutics (KRTX) Stock
by Zacks Equity Research
Karuna Therapeutics (KRTX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
KRTX
medical
Stock Market News for May 20, 2020
by Zacks Equity Research
U.S. stock markets closed lower on Tuesday following the news that a potential vaccine candidate for the treatment of the coronavirus may not be effective.
MRNA LOW
medical retail
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
VRTX QDEL MKTX CHGG DBX
computers medical
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
VRSN VRTX CHGG NLS SFM
medical